Henoch-Schönlein purpura after intravesical administration of bacillus Calmette-Guérin

Henoch-Schönlein purpura after intravesical administration of bacillus Calmette-Guérin

The administration of intravesical bacille Calmette-Guérin (BCG) in early stages of bladder cancer is usually a safe therapy. Side-effects of BCG immunotherapy can be of both local and systemic nature. We report the first case of Henoch-Schönlein purpura following intravesical administration of BCG....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scandinavian journal of infectious diseases 2005, Vol.37 (8), p.613-615
Hauptverfasser: Nan, Daniel N., Fernández-Ayala, Marta, García-Ibarbia, Carmen, Gutiérrez-Santiago, Mar, Hernández, José L.
Format: Artikel
Sprache:eng
Schlagworte:
Administration, Intravesical
Aged
Bacterial diseases
Biological and medical sciences
Dermatology
Human bacterial diseases
Humans
Infectious diseases
Male
Medical sciences
Mycobacterium bovis - pathogenicity
Purpura, Schoenlein-Henoch - etiology
Purpura, Schoenlein-Henoch - physiopathology
Tuberculosis and atypical mycobacterial infections
Urinary Bladder Neoplasms - therapy
Vascular disorders of the skin
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The administration of intravesical bacille Calmette-Guérin (BCG) in early stages of bladder cancer is usually a safe therapy. Side-effects of BCG immunotherapy can be of both local and systemic nature. We report the first case of Henoch-Schönlein purpura following intravesical administration of BCG.
ISSN:0036-5548
1651-1980
DOI:10.1080/00365540510035300